Menu
GeneBe

18-3067280-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003803.4(MYOM1):c.5040T>C(p.Gly1680=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.491 in 1,602,184 control chromosomes in the GnomAD database, including 198,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 25704 hom., cov: 32)
Exomes 𝑓: 0.48 ( 172874 hom. )

Consequence

MYOM1
NM_003803.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.491
Variant links:
Genes affected
MYOM1 (HGNC:7613): (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 18-3067280-A-G is Benign according to our data. Variant chr18-3067280-A-G is described in ClinVar as [Benign]. Clinvar id is 226828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.491 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.783 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYOM1NM_003803.4 linkuse as main transcriptc.5040T>C p.Gly1680= synonymous_variant 38/38 ENST00000356443.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYOM1ENST00000356443.9 linkuse as main transcriptc.5040T>C p.Gly1680= synonymous_variant 38/381 NM_003803.4 P2P52179-1
MYOM1ENST00000261606.11 linkuse as main transcriptc.4752T>C p.Gly1584= synonymous_variant 37/371 A2P52179-2
MYOM1ENST00000581804.1 linkuse as main transcriptn.530T>C non_coding_transcript_exon_variant 3/33

Frequencies

GnomAD3 genomes
AF:
0.562
AC:
85401
AN:
151940
Hom.:
25666
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.790
Gnomad AMI
AF:
0.470
Gnomad AMR
AF:
0.400
Gnomad ASJ
AF:
0.473
Gnomad EAS
AF:
0.531
Gnomad SAS
AF:
0.577
Gnomad FIN
AF:
0.585
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.465
Gnomad OTH
AF:
0.501
GnomAD3 exomes
AF:
0.498
AC:
116783
AN:
234312
Hom.:
30026
AF XY:
0.500
AC XY:
63562
AN XY:
127104
show subpopulations
Gnomad AFR exome
AF:
0.788
Gnomad AMR exome
AF:
0.348
Gnomad ASJ exome
AF:
0.464
Gnomad EAS exome
AF:
0.529
Gnomad SAS exome
AF:
0.568
Gnomad FIN exome
AF:
0.589
Gnomad NFE exome
AF:
0.469
Gnomad OTH exome
AF:
0.479
GnomAD4 exome
AF:
0.484
AC:
701689
AN:
1450126
Hom.:
172874
Cov.:
58
AF XY:
0.485
AC XY:
349646
AN XY:
720332
show subpopulations
Gnomad4 AFR exome
AF:
0.799
Gnomad4 AMR exome
AF:
0.360
Gnomad4 ASJ exome
AF:
0.470
Gnomad4 EAS exome
AF:
0.540
Gnomad4 SAS exome
AF:
0.567
Gnomad4 FIN exome
AF:
0.585
Gnomad4 NFE exome
AF:
0.465
Gnomad4 OTH exome
AF:
0.501
GnomAD4 genome
AF:
0.562
AC:
85495
AN:
152058
Hom.:
25704
Cov.:
32
AF XY:
0.564
AC XY:
41922
AN XY:
74316
show subpopulations
Gnomad4 AFR
AF:
0.790
Gnomad4 AMR
AF:
0.400
Gnomad4 ASJ
AF:
0.473
Gnomad4 EAS
AF:
0.530
Gnomad4 SAS
AF:
0.577
Gnomad4 FIN
AF:
0.585
Gnomad4 NFE
AF:
0.465
Gnomad4 OTH
AF:
0.500
Alfa
AF:
0.463
Hom.:
24980
Bravo
AF:
0.557
Asia WGS
AF:
0.551
AC:
1914
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Gly1680Gly in exon 38 of MYOM1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 46.6% (3990/8554) of European American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2230164). -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 07, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 13, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hypertrophic cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
Cadd
Benign
0.75
Dann
Benign
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230164; hg19: chr18-3067278; COSMIC: COSV55294376; API